Mountain State Medical Policy Bulletin

Section: Radiation Therapy & Nuclear Medicine
Number: R-16
Topic: PET/CT Fusion Imaging for Tumor Localization
Effective Date: August 1, 2005
Issued Date: August 1, 2005
Date Last Reviewed: 06/2005

General Policy Guidelines

Indications and Limitations of Coverage

All eligibility criteria and coverage guidelines that apply to PET studies will also apply to PET/CT fusion imaging based on the anatomic area imaged. This policy focuses on the PET/CT fusion imaging for tumor localization in diagnosing and treating various malignancies. For information on PET imaging as the sole imaging modality for oncologic applications, refer to Medical Policy Bulletin R-9.

All eligible diagnosis codes for covered PET studies will also apply to PET/CT fusion imaging. PET/CT fusion imaging reported with a diagnosis code other than those listed as eligible will be denied as not medically necessary. A participating, preferred, or network provider cannot bill the member for the denied service. 

Description

Multi-modality image co-registration (also known as fusion or co-registered imaging) is useful in certain clinical situations because data acquired from CT or MRI studies and PET studies yields complementary information. In PET/CT fusion imaging, the anatomic information from the SPECT/CT images is combined or "fused" with the physiologic information obtained from the PET images to localize tumors or lesions especially in regions of complex anatomy, such as in the head, neck, chest, abdomen and pelvis. 

There are two methods of PET/CT co-registered or fusion imaging. One method involves the use of special computer software that combines or "fuses" the anatomic information from previously acquired the SPECT/CT images with the physiologic or functional information obtained from the PET study. This software fusion method is more labor intensive and at times unsuccessful, because the patient is imaged by two different modalities during two different imaging sessions. The patient is not in the same position or alignment for both studies, patient movement is different during two separate imaging sessions as well as the involuntary and uncontrollable motion of internal organs. 

The other method uses a single combination PET/CT scanner that takes simultaneous PET and CT images. When compared to PET studies performed alone, using the co-registered images of a single combined PET/CT study improves lesion classification and staging performance, and reduces scanning time. In this situation, the patient remains positioned on the same bed for both imaging modalities, minimizing both temporal, motion and spatial differences between the images acquired. In addition, using the single scan for both modalities makes the images available for viewing while the patient is still in the scanner.

For additional information on CT scans, refer to Mountain State Medical Policy Bulletin X-3.

For additional information on PET tumor localization, refer to Mountain State Medical Policy Bulletin R-9.


NOTE:
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Procedure Codes

788147881578816   

Traditional Guidelines

Refer to General Policy Guidelines

FEP Guidelines

Refer to General Policy Guidelines

PPO Guidelines

Refer to General Policy Guidelines

Managed Care POS Guidelines

Refer to General Policy Guidelines

Publications

PRN References

12/2004, 2005 HCPCS update revision packet

References

PET/CT Fusion Proves Its Value, Diagnostic Imaging, Vol. 24, No. 6, June 2002

Staging of Non-small Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed Tomography, The New England Journal of Medicine, Vol. 348, No. 25, June 2003

PET/CT Today and Tomorrow, The Journal of Nuclear Medicine, Vol. 45, No.1 (Suppl), January 2004

Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion, Radiology, Vol. 231, No. 1, April 2004

Radiology Rounds: A Newsletter for Referring Physicians Massachusetts General Hospital, Department of Radiology, Vol. 2, No. 5, May 2004

PET and PET-CT for evaluation of colorectal carcinoma, Seminars in Nuclear Medicine, Vol. 34, No. 3, July 2004

Image-guided cancer therapy using PET/CT, The Cancer Journal, Vol. 10, No. 4, July-August 2004

Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer, The Cancer Journal, Vol. 10, No. 4, July-August 2004

PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake, Radiographics, Vol. 24, No. 5, September-October 2004

View Previous Versions

No Previous Versions

Table Attachment

Eligible Diagnosis Codes by Anatomic Area

Brain

191.0-191.9

198.3

 

 

Breast

174.0-174.9

175.0-175.9

198.81

233.0

238.3

239.3

 

 

Colorectal

153.0-153.9

154.0-154.8

155.0

197.5

230.3

230.4

230.5

235.2

239.0

 

 

 

Esophageal

150.0-150.9

151.0

230.1

235.5

239.0

 

 

 

Head & Neck

140.0-140.9

141.0-141.9

142.0-142.9

143.0-143.9

144.0-144.9

145.0-145.9

146.0-146.9

147.0-147.9

148.0-148.9

149.0-149.9

160.0-160.9

161.0-161.9

162.0

162.2

170.0-170.1

171.0

173.0-173.4

176.2

190.0-190.9

194.1

194.3

195.0

196.0

210.0-210.9

212.0-212.1

213.0-213.1

215.0

216.0-216.4

224.0-224.9

228.03

230.0

231.0

231.1

231.8

232.0-232.4

234.0

235.0-235.1

235.6

237.0

238.0

238.2

238.8

239.0

239.1

239.2

239.8

 

 

Lung

162.0-162.9

163.0-163.9

164.8

164.9

196.1

197.0

197.1

231.2

235.7

235.8

239.1

518.89

Lymphoma

196.1

200.00-200.88

201.00-201.98

202.00-202.98

Melanoma

172.0-172.9

 

 

 

Pancreas

157.0-157.9

 

 

 

Thyroid

193

234.8

237.4

 


 

Text Attachment

Procedure Code Attachment


Glossary





This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Medical policies are designed to supplement the terms of a member's contract. The member's contract defines the benefits available; therefore, medical policies should not be construed as overriding specific contract language. In the event of conflict, the contract shall govern.

Medical policies do not constitute medical advice, nor the practice of medicine. Rather, such policies are intended only to establish general guidelines for coverage and reimbursement under Mountain State Blue Cross Blue Shield plans. Application of a medical policy to determine coverage in an individual instance is not intended and shall not be construed to supercede the professional judgment of a treating provider. In all situations, the treating provider must use his/her professional judgment to provide care he/she believes to be in the best interest of the patient, and the provider and patient remain responsible for all treatment decisions.

Mountain State Blue Cross Blue Shield (MSBCBS) retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of MSBCBS. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.